Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.55 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | TACR1 | P25103 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.42 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 2/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | CPA3 | P15088 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10022854 | 1.00 | GABBR2 (0.55) | GABBR2GABBR1CYP2C19TACR1KMT2A | |
| SCHEMBL618203 | 1.00 | GABBR2 (0.55) | GABBR2GABBR1CYP2C19TACR1KMT2A | |
| SCHEMBL19143349 | 0.84 | TACR1 (0.43) | GABBR2GABBR1CYP2C19TACR1SMN1; SMN2 | |
| SCHEMBL31369450 | 0.82 | CYP2C9 (0.60) | GABBR2GABBR1CYP2C19KMT2ACYP2D6 | |
| SCHEMBL7876564 | 0.82 | GABBR2 (0.53) | GABBR2GABBR1CYP2C19KMT2ASMN1; SMN2 | |
| SCHEMBL1667061 | 0.80 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19KMT2ASMN1; SMN2 | |
| SCHEMBL1667437 | 0.80 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19KMT2ASMN1; SMN2 | |
| SCHEMBL5144343 | 0.80 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19KMT2ASMN1; SMN2 | |
| SCHEMBL1666942 | 0.80 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19MAPT | |
| SCHEMBL1669595 | 0.80 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3208279-B1 | MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF | UNIV CALIFORNIA (US) | 2021-04-21 | — | — | EP | claimed |
| US-9896481-B2 | Modified mini-hepcidin peptides and methods of using thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-20 | — | — | US | claimed |
| EP-2373679-B1 | MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF | UNIV CALIFORNIA (US) | 2017-03-08 | — | — | EP | claimed |
| US-8435941-B2 | Mini-hepcidin peptides and methods of using thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-05-07 | — | — | US | claimed |
| US-8034787-B2 | Enzyme-cleavable prodrug compounds | MEDAREX, INC. (US) | 2011-10-11 | — | — | US | claimed |
| EP-1404356-B1 | METHOD FOR DESIGNING CD10-ACTIVATED PRODRUG COMPOUNDS | MEDAREX INC (US) | 2011-04-06 | — | — | EP | claimed |
| EP-1144011-B1 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COULTER PHARM INC (US) | 2010-03-10 | — | — | EP | claimed |
| US-20090110753-A1 | Enzyme-cleavable prodrug compounds | MEDAREX, INC. (US) | 2009-04-30 | — | — | US | claimed |
| US-7425541-B2 | Enzyme-cleavable prodrug compounds | MEDAREX, INC. (US) | 2008-09-16 | — | — | US | claimed |
| US-7115573-B2 | Prodrug compounds with an isoleucine | MEDAREX, INC. (US) | 2006-10-03 | — | — | US | claimed |
| US-20040039160-A1 | Prodrug compounds with an oligopeptide having an isoluecine residue | E. R. SQUIBB & SONS, L.L.C. | 2004-02-26 | — | — | US | claimed |
| EP-1294405-A2 | PRODRUG COMPOUNDS CLEAVABLE BY THIMET OLIGOPEPTIDASE | CORIXA CORPORATION (US) | 2003-03-26 | — | — | EP | claimed |
| EP-1294404-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | CORIXA CORPORATION (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2002100353-A2 | CD10-ACTIVATED PRODRUG COMPOUNDS | MEDAREX, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| US-20020142955-A1 | Enzyme-cleavable prodrug compounds | E. R. SQUIBB & SONS, L.L.C. | 2002-10-03 | — | — | US | claimed |
| WO-2001095943-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| WO-2001095945-A2 | PRODRUG COMPOUNDS CLEAVABLE BY THIMET OLIGOPEPTIDASE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| EP-1144011-A2 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | Coulter Pharmaceutical, Inc. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000033888-A9 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COULTER PHARM INC (US) | 2001-05-10 | — | — | WO | claimed |
| WO-2000033888-A2 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COULTER PHARMACEUTICAL, INC. (US) | 2000-06-15 | — | — | WO | claimed |